Clarivate (NYSE:CLVT) Trading Down 5.2% – Here’s What Happened

Clarivate PLC (NYSE:CLVT) shares were down 5.2% on Monday . The company traded as low as $2.31 and last traded at $2.4560. Approximately 1,353,782 shares changed hands during trading, a decline of 80% from the average session volume of 6,680,027 shares. The stock had previously closed at $2.59.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Barclays upped their target price on shares of Clarivate from $2.40 to $2.50 and gave the company an “underweight” rating in a research report on Tuesday. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Clarivate in a research note on Wednesday, June 24th. Five equities research analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, Clarivate currently has an average rating of “Reduce” and an average target price of $3.23.

Clarivate Stock Performance

The stock’s 50-day moving average is $2.41 and its 200 day moving average is $2.56. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.84 and a current ratio of 0.84. The firm has a market cap of $1.61 billion, a P/E ratio of -11.96 and a beta of 1.38.

Clarivate (NYSE:CLVT) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.04. Clarivate had a positive return on equity of 8.82% and a negative net margin of 5.61%.The company had revenue of $585.50 million during the quarter, compared to the consensus estimate of $569.50 million. During the same period in the prior year, the company earned $0.14 earnings per share. The company’s revenue for the quarter was down 1.4% compared to the same quarter last year. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. On average, research analysts predict that Clarivate PLC will post 0.65 earnings per share for the current year.

Institutional Investors Weigh In On Clarivate

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. M&T Bank Corp acquired a new position in Clarivate in the 4th quarter worth $34,000. PharVision Advisers LLC acquired a new stake in shares of Clarivate in the 3rd quarter valued at about $45,000. Personal CFO Solutions LLC acquired a new stake in shares of Clarivate in the 1st quarter valued at about $30,000. FreeGulliver LLC bought a new stake in shares of Clarivate in the first quarter valued at about $30,000. Finally, Pitcairn Co. bought a new stake in shares of Clarivate in the second quarter valued at about $52,000. 85.72% of the stock is currently owned by institutional investors and hedge funds.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.